Indian drug major Sun pharmaceuticals has secured tentative approval from the United States Food and Drugs administration for the generic version of gleeven, used to treat chronic myeloid leukaemia. The drug will be available in two strengths of 100 mg and 400 mg and the market size for them is estimated at nearly $900 million.crackcrack

Sun Pharma Inds. Share Price

1634.40 21.85 (1.35%)
22-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.40
Dr. Reddys Lab 1217.15
Cipla 1371.55
Zydus Lifesciences 884.85
Lupin 2165.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×